|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006118,
umls-concept:C0013216,
umls-concept:C0205225,
umls-concept:C0205282,
umls-concept:C0525063,
umls-concept:C0680844,
umls-concept:C0681916,
umls-concept:C0750572,
umls-concept:C0920687,
umls-concept:C1521828,
umls-concept:C2698651
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-27
|
|
pubmed:abstractText |
The optimal chemotherapy utilisation rate can serve as a benchmark to assess the quality of cancer care. The aim of this study was to determine the optimal proportion of patients with primary malignant brain tumours for whom there was evidence that they should receive chemotherapy at least once.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1433-2981
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
48-54
|
|
pubmed:meshHeading |
pubmed-meshheading:20951557-Antineoplastic Agents,
pubmed-meshheading:20951557-Benchmarking,
pubmed-meshheading:20951557-Brain Neoplasms,
pubmed-meshheading:20951557-Evidence-Based Medicine,
pubmed-meshheading:20951557-Guideline Adherence,
pubmed-meshheading:20951557-Humans,
pubmed-meshheading:20951557-Neoplasm Recurrence, Local,
pubmed-meshheading:20951557-Practice Guidelines as Topic,
pubmed-meshheading:20951557-Quality Indicators, Health Care,
pubmed-meshheading:20951557-Randomized Controlled Trials as Topic,
pubmed-meshheading:20951557-SEER Program,
pubmed-meshheading:20951557-Sensitivity and Specificity
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care.
|
|
pubmed:affiliation |
University of New South Wales and Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital, Liverpool, New South Wales, Australia. Susannah.Jacob@sswahs.nsw.gov.au
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
